Vothiaxetine Hydrobromide API

Name	Vothiaxetine hydrobromide
Chinese name	氢溴酸伏硫西汀
Cas Number	960203-27-4
Source	India
Qualifications	USDMF/-/-/-/-

Futhiaxetine was originally developed by Lundbeck, Denmark. It is a new multimodal antidepressant that can not only block the 5-HT reuptake by the 5-HT transporter (SERT), but also increase the central 5-HT It can also regulate multiple 5-HT receptors and exert a more comprehensive pharmacological effect, which is different from the existing 5-HT reuptake inhibitors. Since it was approved for marketing in the United States in 2013, its efficacy in symptom improvement has been verified in numerous clinical practices. Up to now, it has obtained marketing approval from regulatory agencies in more than 70 countries and regions around the world. In addition, the incidence of adverse events of vothiaxetine is significantly lower than that of traditional antidepressants. It is expected that this product will be a hot spot for antidepressant imitation in the next few years.

Hot Tags: vothiaxetine hydrobromide api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Bosentan API, Dimethyl Fumarate API, Lifitegrast API, Paliperidone API, Cinacalcet Hydrochloride API, Vardenafil API

• Previous: Doxylamine Succinate API
• Next: Clobetasol Propionate API